APH vs TRDA · P/E 40, rev $23.09B vs P/E 12, rev $210.8M
Amphenol Corporation (APH) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
APH currently screens at market cap $170.77B and trailing P/E 39.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the APH and TRDA stock pages for the full models.
Not investment advice.